Agitation In Alzheimer's Disease
Reasonable travel expenses such as travel by taxi, may be reimbursed.
Food may be provided during long study visits if needed.
About This clinical research study
With an ageing population, medications to help treat the symptoms of Alzheimer’s disease (AD) become more needed than ever.
Statistics show that around 80% of patients show signs of agitation and aggression with an increase in prevalence as the disease progresses. Here at MAC, we understand that the condition is incredibly difficult to deal with.
Reasonable travel expenses such as travel by taxi, may be reimbursed.
Food may be provided during long study visits if needed.
Clinics
South Staffordshire
Therapy Area
Dementia
Gender and Age
Males and Females aged 50 - 90
A full description of the study will be given before you decide to take part, both over the phone and during an appointment at a MAC clinic. This will include you receiving the full Patient Information Sheet.
If you contact us, it does not mean you have to decide at that point whether to participate.
If you do decide to participate you are free to withdraw at any time.
The clinical research study being run at the MAC site in Cannock, South Staffordshire is a Phase III, 16-week study to assess a new investigational drug that may help alleviate symptoms of agitation associated with Alzheimer’s disease. Over the 16-week period, there’ll be a total of 7 visits to the clinic and 2 phone calls from a study doctor. The investigational drug is known at present as AVP-786. By participating you may be helping to contribute to the development of a new therapy for agitation in Alzheimer’s disease that may help improve the quality of life for many people.
Reimbursement:Â Reasonable travel expenses such as travel by taxi, may be reimbursed. Food may be provided during long study visits if needed.
Key Inclusion Criteria
- Men and women aged between 50 - 90
- A diagnosis of Alzheimer’s disease
- Symptoms of agitation associated with Alzheimer’s disease
Key Exclusion Criteria
- An uncontrolled or unstable medical condition
- Dementia of the non-Alzheimer’s type: vascular, frontotemporal, Parkinson’s etc
Other eligibility criteria will apply. Please contact MAC for more information.
ABOUT CLINICAL RESEARCH STUDIES
Clinical research studies are performed as a way of bringing about progress in medicine and research. Clinical research studies make it possible to scientifically assess the properties of a drug, to demonstrate the effectiveness and safety of a treatment or a medical device, or to learn more about a disease and methods to diagnose and monitor it.
If the study is successful, it may be an important step towards developing a promising new treatment.
MAC Clinical Research is currently conducting a trial to test a new potential treatment for agitation in Alzheimer’s disease.
If you would like more information, please fill in the form below and we will be in touch…
Alternatively, please call our recruitment team on freephone 0800 633 5507.
Know someone who may be interested in taking part? Share this page here:
